| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/22/1993 | CA2128323A1 Mammalian adipogenic factors |
| 07/22/1993 | CA2127532A1 Antibodies recognizing the fourth immunoglobulin-like domain of vcam1 |
| 07/22/1993 | CA2127473A1 Peptides of the casein macropeptide, antibodies directed against said peptides and applications |
| 07/22/1993 | CA2127368A1 Platelet transfusion |
| 07/22/1993 | CA2126094A1 Induced tolerence to xenografts |
| 07/22/1993 | CA2125701A1 Hepatitis e virus vaccine and method |
| 07/22/1993 | CA2125700A1 Hepatitis e virus peptide antigens and antibodies |
| 07/22/1993 | CA2123576A1 Synthetic peptides for detoxification of bacterial endotoxins and treatment of septic shock |
| 07/22/1993 | CA2105284A1 Dna encoding a human 5-ht 1f receptor and uses thereof |
| 07/21/1993 | EP0552031A1 Oxepane isomers of rapamycin useful as immunosuppressive agents |
| 07/21/1993 | EP0551916A2 Process for stabilisation of proteins |
| 07/21/1993 | EP0551501A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 07/21/1993 | EP0551460A1 HCV peptide-antigens and a method of testing for the hepatitis C virus (HCV) |
| 07/21/1993 | EP0551440A1 Design of bioactive peptides based on immunoglobulin structure |
| 07/21/1993 | EP0551400A1 Method for treating inflammation using anti-idiotypic antibodies |
| 07/21/1993 | EP0551325A1 Method of testing for salmonella |
| 07/21/1993 | EP0551308A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 07/21/1993 | EP0536215A4 Neurofibromatosis gene |
| 07/21/1993 | EP0242359B1 A cloning vehicle for cloning a large fragment of dna and a vaccine comprising 987p fimbrial protein |
| 07/21/1993 | EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 07/20/1993 | US5229500 Brain derived neurotrophic factor |
| 07/20/1993 | US5229498 Method of cleansing a protein from multivalent metal ions bound thereto |
| 07/20/1993 | US5229495 Transforming growth factor |
| 07/20/1993 | US5229494 Receptor for natural killer and non-specific cytotoxic cells |
| 07/20/1993 | US5229364 Polypeptides derived from the human immunodeficiency virus endonuclease protein |
| 07/20/1993 | US5229289 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
| 07/20/1993 | US5229275 Transforming lymphocytes using 8-mercaptoguanosine and interleukin adjuvants |
| 07/20/1993 | US5229272 Catalytic antibody components |
| 07/20/1993 | US5229267 Assay for evaluating inhibition of PMN elastase by N-substituted azetidinones |
| 07/20/1993 | US5229110 Process for preparing a vaccine against malaria |
| 07/20/1993 | CA1320461C Monoclonal antibody capable of recognizing human arteriosclerosis and process for preparing same |
| 07/20/1993 | CA1320460C Anti-human gastric cancer monoclonal antibody |
| 07/20/1993 | CA1320459C Anti-human pulmonary carcinoma monoclonal antibody |
| 07/15/1993 | WO1993014408A1 Myotonin receptors and screening methods |
| 07/15/1993 | CA2105167A1 Myotonin receptors and screening methods |
| 07/14/1993 | EP0551084A2 Human antithrombin-III preparation |
| 07/14/1993 | EP0550955A2 Chimeric antibody against human GMP-140 |
| 07/14/1993 | EP0550691A1 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides. |
| 07/14/1993 | EP0550663A1 Modified antibodies with controlled clearance time |
| 07/14/1993 | EP0550661A1 Gro genes, proteins, and uses thereof |
| 07/14/1993 | EP0550645A1 Surface expression libraries of heteromeric receptors |
| 07/14/1993 | EP0550561A1 Purification of cytokeratin fragments |
| 07/14/1993 | EP0550528A1 Active site of interleukin-8: polypeptide analogs and antibodies |
| 07/14/1993 | EP0550519A1 Nucleotide sequences coding for a human protein with angiogenesis regulative properties |
| 07/14/1993 | EP0550516A1 Method for inhibiting the infectivity of human immunodeficiency virus |
| 07/14/1993 | EP0550506A1 Novel chemotactic factor |
| 07/14/1993 | EP0550500A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF PROTEIN MTP40 OF $i(M. TUBERCULOSIS) AND SYNTHETIC PEPTIDES DERIVED THEREFROM |
| 07/14/1993 | EP0550482A1 Methods for inhibiting rejection of transplanted tissue |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/13/1993 | US5227472 3-Methoxy-4-hydroxyphenylethylene glycol |
| 07/13/1993 | US5227471 Monoclonal antibody PD41 that binds to a prostate mucin antigen that is expressed in human prostatic carcinoma |
| 07/13/1993 | US5227369 Carbohydrate blocking agent which inhibits LHR-mediated binding of leukocytes to myelin |
| 07/13/1993 | US5227368 Endotoxin-induced thrombosis factor which induces procoagulant activity in endothelial cells |
| 07/13/1993 | US5227302 DNA encoding platelet derived endothelial cell growth factor (PD-ECGF) |
| 07/13/1993 | US5227160 Contraceptives, treatment of infertility |
| 07/13/1993 | US5227159 Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies |
| 07/13/1993 | US5226914 Method for treating connective tissue disorders |
| 07/13/1993 | CA1320160C Monoclonal antibodies against ifn-omega, processes for preparing them and their use in the purification and detection of ifn-omega |
| 07/08/1993 | WO1993014110A1 Method for isolating biomolecules with linear polymers |
| 07/08/1993 | WO1993013421A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | WO1993013417A1 Receptor/oncogene growth factor system in breast cancer |
| 07/08/1993 | WO1993013222A1 Dna structure-specific recognition protein and uses therefor |
| 07/08/1993 | WO1993013211A1 Expression and purification of recombinant soluble tissue factor |
| 07/08/1993 | WO1993013210A1 Icams immunoglobulin constant region soluble fusion proteins |
| 07/08/1993 | WO1993013209A1 Expression signal-peptide-free staphylokinases |
| 07/08/1993 | WO1993013205A1 Neuroblastoma-associated regulator gene |
| 07/08/1993 | WO1993013201A1 Lipopolysaccharide binding opsonin inhibitor and methods of use thereof |
| 07/08/1993 | WO1993013134A1 Monoclonal antibody to hiv-2 and uses thereof |
| 07/08/1993 | WO1993013133A1 HUMAN TYPE ANTIBODY REACTIVE WITH GPIIb/IIIa |
| 07/08/1993 | WO1993013130A1 Somatostatin receptors |
| 07/08/1993 | WO1993013127A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | WO1993013119A1 Hematopoietic cell specific transcriptional regulatory elements of serglycin and uses thereof |
| 07/08/1993 | WO1993013093A1 Oxiranyl methyl ethers exhibiting chirality, and their use as dopants in liquid-crystal mixtures |
| 07/08/1993 | WO1993013089A1 Macrocyclic polyether carboxylic acids |
| 07/08/1993 | WO1993012816A1 Monoclonal antibodies against type i phospholipase a2, used as a therapeutic agent to reduce inflammation |
| 07/08/1993 | DE4200049A1 New monoclonal antibodies specific for tumour necrosis factor binding protein |
| 07/08/1993 | DE4143279A1 New DNA sequence encoding staphylokinase - with corresp. proteins used as plasminogen activators in treatment of thrombosis |
| 07/08/1993 | CA2126693A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus |
| 07/08/1993 | CA2126247A1 Monoclonal antibody to hiv-2 and uses thereof |
| 07/08/1993 | CA2126209A1 Immunochemical detection of in vivo advanced glycosylation endproducts |
| 07/08/1993 | CA2117293A1 Neuroblastoma-associated regulator gene |
| 07/08/1993 | CA2104772A1 Method for isolating biomolecules with linear polymers |
| 07/07/1993 | EP0550400A2 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 07/07/1993 | EP0550020A2 Anti-human IgE monoclonal antibodies |
| 07/07/1993 | EP0549755A1 ddI IMMUNOASSAYS, DERIVATIVES, CONJUGATES AND ANTIBODIES |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549691A1 Gene therapy for cystic fibrosis |
| 07/07/1993 | EP0549662A1 Plasmodium liver stage antigens |
| 07/06/1993 | US5225541 Composition containing CEA/NCA-specific monoclonal antibody XMMBR-B14 conjugated to a detectable moiety and a kit containing the antibody |
| 07/06/1993 | US5225540 Hybridomas and Fab fragments |
| 07/06/1993 | US5225539 Recombinant altered antibodies and methods of making altered antibodies |
| 07/06/1993 | US5225534 Immunology for malaria |
| 07/06/1993 | US5225354 Binding glycosylated lysine in albumin to monoclonal antibodies |
| 07/06/1993 | US5225331 Immunoassay for detecting group b streptococcus |
| 07/06/1993 | US5225181 Labeling with radioactive iodine or metal |
| 07/06/1993 | CA1319899C Monoclonal antibodies to fc receptors for immunoglobulin g on human mononuclear phagocytes |
| 07/01/1993 | DE4143139A1 Chirale oxiranylmethyl-ether und ihre verwendung als dotierstoffe in fluessigkristallmischungen Chiral oxiranylmethyl ethers and their use as dopants in fluessigkristallmischungen |
| 06/30/1993 | EP0549525A2 Monoclonal antibodies against sulfonylureum herbicides and their use for detection |
| 06/30/1993 | EP0548867A2 Soluble stem cell factor (SFC)-receptor |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |